3,4-DISUBSTITUTED MALEIMIDES FOR USE AS VASCULAR DAMAGING AGENTS - Patent 1742911

(19)

(11)

EP 1 742 911 A1

(12)

(43)	Date of publication:
	17.01.2007 Bulletin 2007/03

(21)	Application number: 05738031.3

(22)	Date of filing: 22.04.2005

(51)

International Patent Classification (IPC):

C07D 207/44^(2006.01)
C07F 9/09^(2006.01)
C07D 401/12^(2006.01)
A61K 31/661^(2006.01)

C07F 9/12^(2006.01)
C07D 401/04^(2006.01)
A61K 31/4015^(2006.01)
A61P 35/00^(2006.01)

(86)	International application number:
	PCT/GB2005/001553

(87)	International publication number:
	WO 2005/102997 (03.11.2005 Gazette 2005/44)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

(30)

Priority:

26.04.2004 EP 04291074

(71)	Applicant: AstraZeneca AB
	S-151 85 Södertälje (SE)

(72)	Inventors:
	ARNOULD, Jean-Claude, AstraZeneca Pharma 51689 Reims Cedex 2 (FR) HARRIS, Craig Steven, AstraZeneca Pharma 51689 Reims Cedex 2 (FR) BOYLE, Francis Thomas, AstraZeneca R & D Alderely Macclesfield, Cheshire SK10 4TG (GB) GIBSON, Keith Hopkinson AstraZeneca R & D Alderley Macclesfield, Cheshire SK10 4TG (GB)

(54)	3,4-DISUBSTITUTED MALEIMIDES FOR USE AS VASCULAR DAMAGING AGENTS